Triple-negative breast cancer (TNBC) is an invasive type of breast carcinoma that lacks expression of the estrogen receptor (ER) and progesterone receptor (PR) as well as human epidermal growth factor receptor 2 (HER2) amplification. This evidence concerns the gene ESR1 and breast carcinoma.